Suppr超能文献

自动巴氏涂片系统定位引导筛查的可行性研究。

A feasibility study of the AutoPap system location-guided screening.

作者信息

Lee J S, Kuan L, Oh S, Patten F W, Wilbur D C

机构信息

NeoPath, Inc., Redmond, Washington 98052, USA.

出版信息

Acta Cytol. 1998 Jan-Feb;42(1):221-6. doi: 10.1159/000331550.

Abstract

OBJECTIVE

To study the feasibility of AutoPap System location-guided screening and to evaluate the accuracy of the AutoPap System in selecting locations of potentially abnormal cellular material, the accuracy of triaging slides using the selected locations and the improvement in laboratory accuracy and workload reduction resulting from a combination of location-guided rescreening and AutoPap System primary screening.

STUDY DESIGN

For the study, 683 conventionally prepared cervical cytologic smears (263 WNL, 184 atypical squamous cells of undetermined significance/atypical glandular cells of undetermined significance, 173 low grade squamous intraepithelial lesions, 55 high grade squamous intraepithelial lesions and 8 cancer slides) were acquired from nine laboratories. The study slides were independently screened to establish study reference diagnoses. The slides were processed on the AutoPap System and screened by cytotechnologists who were guided by the field of view (FOV) locations provided by the AutoPap System. The location-guided information was used either for initial manual screening (location-guided screening or after initial manual screening of the entire slide (location-guided rescreening). The results were compared to the study reference diagnoses. Sensitivity and workload reduction figures were estimated for different slide populations.

RESULTS

The accuracy of location-guided slide triage was high and did not vary significantly over different slide populations. Also, for > 80% of the abnormal slides, the AutoPap System-selected FOV slide locations did contain the most diagnostic cells, which were used to assign an accurate diagnosis to the slide. By combining location-guided rescreening with AutoPap primary screening, the estimated overall location-guided screening false negative fraction (FNF) for LSIL+ slides was approximately 40 times lower than the cytotechnologist-only FNFs, and this improvement was achieved-even at a no review rate of 70%.

CONCLUSION

The feasibility study results showed that the AutoPap System location-guided screening process can triage slides accurately and enhance the overall accuracy of slide diagnosis. The combination of location-guided rescreening and AutoPap primary screening could improve the accuracy and workload of the laboratory.

摘要

目的

研究自动巴氏涂片系统定位引导筛查的可行性,评估自动巴氏涂片系统在选择潜在异常细胞材料位置方面的准确性、使用所选位置对玻片进行分流的准确性,以及定位引导再筛查与自动巴氏涂片系统初筛相结合所带来的实验室准确性提高和工作量减少情况。

研究设计

本研究从9个实验室获取了683份传统制备的宫颈细胞学涂片(263份正常,184份意义不明确的非典型鳞状细胞/意义不明确的非典型腺细胞,173份低级别鳞状上皮内病变,55份高级别鳞状上皮内病变和8份癌涂片)。对研究涂片进行独立筛查以确定研究参考诊断。将涂片在自动巴氏涂片系统上处理,并由细胞技术人员根据自动巴氏涂片系统提供的视野(FOV)位置进行筛查。定位引导信息用于初始手动筛查(定位引导筛查)或在对整个玻片进行初始手动筛查之后(定位引导再筛查)。将结果与研究参考诊断进行比较。针对不同的涂片群体估计敏感性和工作量减少数据。

结果

定位引导玻片分流的准确性很高,并且在不同的涂片群体中没有显著差异。此外,对于超过80%的异常玻片,自动巴氏涂片系统选择的FOV玻片位置确实包含最具诊断价值的细胞,这些细胞用于对玻片做出准确诊断。通过将定位引导再筛查与自动巴氏涂片系统初筛相结合,对于LSIL+涂片,估计的总体定位引导筛查假阴性率(FNF)比仅由细胞技术人员筛查时低约40倍,即使在不复查率为70%的情况下也实现了这种改善。

结论

可行性研究结果表明,自动巴氏涂片系统定位引导筛查过程能够准确地对玻片进行分流,并提高玻片诊断的总体准确性。定位引导再筛查与自动巴氏涂片系统初筛相结合可以提高实验室的准确性和工作量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验